Pharmaceutical Companies
R&D expense tracking, regulatory milestone budgeting, licensing revenue management, and the financial leadership that helps pharma companies manage long development cycles.
Schedule a Discovery CallPharmaceutical companies operate with long development timelines, significant R&D investment before any revenue is generated, complex regulatory milestones, and revenue models that can include licensing fees, royalties, milestone payments, and direct sales. The financial planning required to manage cash through multi-year development cycles while tracking R&D costs, grant funding, and investor capital requires specialized expertise.
A fractional CFO from Pyek Financial provides the same caliber of financial leadership that larger pharmaceutical companies have in-house — tailored for companies in the $2M–$50M revenue range who need senior financial expertise without the full-time cost.
Our fractional CFO services are tailored to the specific financial dynamics of your industry. We provide monthly financial reporting, cash flow forecasting, annual budgeting, KPI framework development, bank and lender relationship management, and the strategic financial thinking that drives better decisions.
Every engagement starts with an assessment of your current financial infrastructure, followed by a clear plan to build the reporting and processes you need. We work alongside your existing team or independently, depending on what makes sense for your business.
The pharmaceutical companies that come to Pyek Financial typically face one or more of these challenges:
If any of these sound familiar, a fractional CFO engagement can typically resolve them within the first 60–90 days while establishing the financial infrastructure to prevent them from recurring.
Pharmaceutical Companies face unique financial complexity that most bookkeepers and generalist accountants aren't equipped to handle. A fractional CFO provides senior-level financial expertise at 20-30% of the cost of a full-time hire, delivering strategic guidance, financial reporting, and the infrastructure needed to support growth.
Companies with $2M-$50M in annual revenue are the ideal fit. At this stage, the business has enough complexity to benefit from strategic financial guidance but typically cannot justify the $250K+ cost of a full-time CFO.
Most engagements show measurable impact within 30-60 days. The first month focuses on financial assessment, quick wins, and establishing baseline reporting. By month two, strategic initiatives and improved reporting are underway.
Our Services
Ongoing strategic financial leadership tailored to the needs of pharmaceutical companies.
Learn moreIndustry-appropriate bookkeeping, monthly close, and financial reporting for pharmaceutical companies.
Learn moreBuy-side and sell-side M&A support — valuation, due diligence, and deal structuring for pharmaceutical companies.
Learn moreProject-based work — accounting system implementation, financial cleanup, and process buildout.
Learn moreSchedule a discovery call and we'll discuss how a fractional CFO can help your business improve financial visibility, manage cash flow, and grow with confidence.
Schedule a Discovery Call